BRET biosensors to study GPCR biology, pharmacology, and signal transduction

Frontiers in Endocrinology

Volumn 3, Issue AUG, 2012, Pages

  Salahpour, Ali ^a   Espinoza, Stefano ^b   Masri, Bernard ^c   Lam, Vincent ^a   Barak, Larry S ^d   Gainetdinov, Raul R ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^c CANCER RESEARCH CENTER OF TOULOUSE   (France)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arrestins; cAMP; EPAC; FRET; GRKs; Screening assay; TAAR1

Indexed keywords

EID: 84874363608     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2012.00105     Document Type: Review

References (59)

1. Ahmed, M.R.,Zhan,X.,Song,X.,Kook, S., Gurevich, V. V., and Gurevich, E. V. (2011). Ubiquitin ligase parkin promotes Mdm2-arrestin interaction but inhibits arrestin ubiquitination. Biochemistry 50, 3749-3763.
2. Allen, J. A., Yost, J. M., Setola, V., Chen, X., Sassano, M. F., Chen, M., Peterson, S., Yadav, P. N., Huang, X. P., Feng, B., Jensen, N. H., Che, X., Bai, X., Frye, S. V., Wetsel, W. C., Caron, M. G., Javitch, J. A., Roth, B. L., and Jin, J. (2011). Discovery of beta-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy. Proc. Natl. Acad. Sci. U.S.A. 108,18488-18493.
3. Angers, S., Salahpour, A., Joly, E., Hilairet, S., Chelsky, D., Dennis, M., and Bouvier, M. (2000). Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc. Natl. Acad. Sci. U.S.A. 97,3684-3689.
4. Audet, N., Gales, C., Archer-Lahlou, E., Vallieres, M., Schiller, P. W., Bouvier, M., and Pineyro, G. (2008). Bioluminescence resonance energy transfer assays reveal ligand-specific conformational changes within preformed signaling complexes containing delta-opioid receptors and heterotrimeric G proteins. J. Biol. Chem. 283,15078-15088.
5. Ayoub, M. A., Damian, M., Gespach, C., Ferrandis, E., Lavergne, O., De Wever, O., Baneres, J. L., Pin, J. P., and Prevost, G. P. (2009). Inhibition of heterotrimeric G protein signaling by a small molecule acting on Galpha subunit. J. Biol. Chem. 284, 29136-29145.
6. Ayoub, M. A., Maurel, D., Binet, V., Fink, M., Prezeau, L., Ansanay, H., and Pin, J. P. (2007). Realtimeanalysisof agonist-inducedactivation of protease-activated receptor 1/Galphai1 protein complex measured by bioluminescence resonance energy transfer in living cells. Mol. Pharmacol. 71, 1329-1340.
7. Ayoub, M. A., and Pfleger, K. D. (2010). Recent advances in bioluminescence resonance energy transfer technologies to study GPCR heteromerization. Curr. Opin. Pharmacol. 10, 44-52.
8. Barak, L. S., Ferguson, S. S., Zhang, J., and Caron, M. G. (1997).Abeta-arrestin/greenfluorescent protein biosensor for detecting G protein-coupled receptor activation. J. Biol. Chem. 272, 2749727500.
9. Barak, L. S., Salahpour, A., Zhang, X., Masri, B., Sotnikova, T. D., Ramsey, A. J., Violin, J. D., Lefkowitz, R. J., Caron, M. G., and Gainetdinov, R. R. (2008). Pharmacological characterization of membrane-expressed humantraceamine-associatedreceptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor. Mol. Pharmacol. 74, 585-594.
10. Beaulieu, J. M., and Gainetdinov, R. R. (2011). The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol. Rev. 63, 182-217.
11. Beaulieu, J. M., Gainetdinov, R. R., and Caron, M. G. (2007). The Akt-GSK3 signaling cascade in the actions of dopamine. Trends Pharmacol. Sci. 28, 166-172.
12. Beaulieu, J. M., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R., and Caron, M. G. (2005). An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmissionandbehavior.Cell 122, 261-273.
13. Beaulieu, J. M., Sotnikova, T. D., Yao, W. D., Kockeritz, L., Woodgett, J. R., Gainetdinov, R. R., and Caron, M. G. (2004). Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc. Natl. Acad. Sci. U.S.A. 101, 5099-5104.
14. Busnelli, M., Sauliere, A., Manning, M., Bouvier, M., Gales, C., and Chini,B. (2012). Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes. J. Biol. Chem. 287, 3617-3629.
15. Charest, P. G., Terrillon, S., and Bouvier, M. (2005). Monitoring agonistpromoted conformational changes of beta-arrestin in living cells by intramolecular BRET. EMBO Rep.6, 334-340.
16. Creese, I., Burt, D. R., and Snyder, S. H. (1976). Dopamine receptor binding predictsclinicalandpharmacological potenciesof antischizophrenicdrugs. Science 192, 481-483.
17. Dalrymple, M. B., Pfleger, K. D., and Eidne, K. A. (2008). G proteincoupled receptor dimers: functional consequences, disease states and drug targets. Pharmacol. Ther. 118, 359-371.
18. DiPilato, L. M., Cheng, X., and Zhang, J. (2004). Fluorescent indicators of cAMP and Epac activation reveal differentialdynamicsof cAMPsignaling within discrete subcellular compartments. Proc. Natl. Acad. Sci. U.S.A. 101,16513-16518.
19. Espinoza, S., Salahpour, A., Masri, B., Sotnikova, T. D., Messa, M., Barak, L. S., Caron, M. G., and Gainetdinov,R.R. (2011).Functional interaction between trace amineassociated receptor 1 and dopamine D2 receptor. Mol. Pharmacol. 80, 416-425.
20. Ferre, S., Navarro, G., Casado, V., Cortes, A., Mallol, J., Canela, E. I., Lluis, C., and Franco, R. (2010). G protein-coupled receptor heteromers as new targets for drug development. Prog. Mol. Biol. Transl. Sci. 91, 41-52.
21. Gales, C., Rebois, R. V., Hogue, M., Trieu, P., Breit, A., Hebert, T. E., and Bouvier, M. (2005). Real-time monitoring of receptor and G-protein interactionsinlivingcells.Nat.Methods 2, 177-184.
22. Hamdan, F. F., Audet, M., Garneau, P., Pelletier, J., and Bouvier, M. (2005). High-throughput screening of G protein-coupled receptor antagonists using a bioluminescence resonance energy transfer 1-based betaarrestin2recruitmentassay.J.Biomol. Screen. 10,463-475.
23. Harikumar, K. G., Happs, R. M., and Miller, L. J. (2008). Dimerization in the absence of higher-order oligomerization of the G proteincoupled secretin receptor. Biochim. Biophys. Acta 1778,2555-2563.
24. Hasbi, A., Devost, D., Laporte, S. A., and Zingg, H. H. (2004). Real-time detection of interactions between the human oxytocin receptor and G protein-coupled receptor kinase-2. Mol. Endocrinol. 18, 1277-1286.
25. Hasbi, A., Nguyen, T., Fan, T., Cheng, R., Rashid, A., Alijaniaram, M., Rasenick, M. M., O'Dowd, B. F., and George, S. R. (2007). Trafficking of preassembled opioid mu-delta heterooligomer-Gz signaling complexes to the plasma membrane: coregulation by agonists. Biochemistry 46, 12997-13009.
26. Hu, L. A., Zhou, T., Ahn, J., Wang, S., Zhou, J., Hu, Y., and Liu, Q. (2009). Human and mouse trace amineassociated receptor 1 have distinct pharmacology towards endogenous monoamines and imidazoline receptor ligands. Biochem. J. 424, 39-45.
27. Huttenrauch, F., Pollok-Kopp, B., and Oppermann, M. (2005). G proteincoupled receptor kinases promote phosphorylation and beta-arrestinmediated internalization of CCR5 homoand hetero-oligomers. J. Biol. Chem. 280,37503-37515.
28. Jiang, L. I., Collins, J., Davis, R., Lin, K. M., DeCamp, D., Roach, T., Hsueh, R., Rebres, R. A., Ross, E. M., Taussig, R., Fraser, I., and Sternweis, P. C. (2007). Use of a cAMP BRET sensor to characterize a novel regulation of cAMP by the sphingosine 1-phosphate/G13 pathway. J. Biol. Chem. 282,10576-10584.
29. Jorgensen, R., Holliday, N. D., Hansen, J. L., Vrecl, M., Heding, A., Schwartz, T. W., and Elling, C. E. (2008). Characterization of Gproteincoupledreceptorkinaseinteraction with the neurokinin-1 receptor using bioluminescence resonance energy transfer. Mol. Pharmacol. 73, 349-358.
30. Jorgensen, R., Norklit Roed, S., Heding, A., and Elling, C. E. (2011). Betaarrestin2 as a competitor for GRK2 interaction with the GLP-1 receptor uponreceptoractivation.Pharmacology 88, 174-181.
31. Kuravi, S., Lan, T. H., Barik, A., and Lambert, N. A. (2010). Third-party bioluminescence resonance energy transfer indicates constitutive association of membrane proteins: application to class a g-protein-coupled receptors and g-proteins. Biophys. J. 98, 2391-2399.
32. Lavine, N., Ethier, N., Oak, J. N., Pei, L., Liu, F., Trieu, P., Rebois, R. V., Bouvier, M., Hebert, T. E., and Van Tol, H. H. (2002). G protein-coupled receptors form stable complexes with inwardly rectifying potassium channels and adenylyl cyclase. J. Biol. Chem. 277,46010-46019.
33. Lefkowitz, R. J., and Shenoy, S. K. (2005). Transduction of receptor signals by beta-arrestins. Science 308, 512-517.
34. Lindemann, L., Meyer, C. A., Jeanneau, K., Bradaia, A., Ozmen, L., Bluethmann, H., Bettler, B., Wettstein, J. G., Borroni, E., Moreau, J. L., and Hoener, M. C. (2008). Trace amine-associated receptor 1 modulates dopaminergic activity. J. Pharmacol. Exp. Ther. 324, 948-956.
35. Lohse, M. J., Hein, P., Hoffmann, C., Nikolaev, V. O., Vilardaga, J. P., and Bunemann, M. (2008). Kinetics of G-protein-coupled receptor signals in intact cells. Br. J. Pharmacol. 153(Suppl. 1),S125-S132.
36. Lohse, M. J., Nuber, S., and Hoffmann, C. (2012). Fluorescence/bioluminescence resonance energy transfer techniques to study G-protein-coupled receptor activation and signaling. Pharmacol. Rev. 64, 299-336.
37. Marullo, S., and Bouvier, M. (2007). Resonance energy transfer approaches in molecular pharmacology and beyond. Trends Pharmacol. Sci. 28,362-365.
38. Masri, B., Salahpour, A., Didriksen, M., Ghisi, V., Beaulieu, J. M., Gainetdinov, R. R., and Caron, M. G. (2008). Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics. Proc. Natl. Acad. Sci. U.S.A. 105, 13656-13661.
39. Milligan, G. (2009). G protein-coupled receptorhetero-dimerization:contribution to pharmacology and function. Br. J. Pharmacol. 158,5-14.
40. Milligan,G. (2010). The role of dimerisation in the cellular trafficking of G-protein-coupled receptors. Curr. Opin. Pharmacol. 10,23-29.
41. Namkung, Y., Dipace, C., Javitch, J. A., and Sibley, D. R. (2009). G protein-coupled receptor kinasemediated phosphorylation regulates post-endocytic trafficking of the D2 dopamine receptor. J. Biol. Chem. 284,15038-15051.
42. Ni,Q.,Titov,D.V.,andZhang,J.(2006). Analyzing protein kinase dynamics in living cells with FRET reporters. Methods 40, 279-286.
43. Oner, S. S., Maher, E. M., Breton, B., Bouvier, M., and Blumer, J. B. (2010). Receptor-regulated interaction of activator of G-protein signaling-4 and Galphai. J. Biol. Chem. 285,20588-20594.
44. Perroy, J., Pontier, S., Charest, P. G., Aubry, M., and Bouvier, M. (2004). Real-time monitoring of ubiquitination in living cells by BRET. Nat. Methods 1,203-208.
45. Pfleger, K. D., Dalrymple, M. B., Dromey, J. R., and Eidne, K. A. (2007). Monitoring interactions between G-protein-coupled receptors and beta-arrestins. Biochem. Soc. Trans. 35,764-766.
46. Pfleger, K. D., and Eidne, K. A. (2003). New technologies: bioluminescence resonance energy transfer (BRET) for the detection of real timeinteractionsinvolvingG-protein coupled receptors. Pituitary 6, 141-151.
47. Pfleger, K. D., and Eidne, K. A. (2006). Illuminating insights into protein-protein interactions using bioluminescence resonance energy
48. Prinz, A., Diskar, M., Erlbruch, A., and Herberg, F. W. (2006). Novel, isotype-specific sensors for protein kinaseAsubunitinteractionbasedon bioluminescence resonance energy transfer (BRET). Cell Signal. 18, 1616-1625.
49. Reiter, E., and Lefkowitz, R. J. (2006). GRKs and beta-arrestins: roles in receptorsilencing,traffickingandsignaling. Trends Endocrinol. Metab. 17, 159-165.
50. Revel, F. G., Moreau, J. L., Gainetdinov, R. R., Bradaia, A., Sotnikova, T. D., Mory, R., Durkin, S., Zbinden, K. G., Norcross, R., Meyer, C. A., Metzler,V.,Chaboz,S.,Ozmen,L.,Trube, G., Pouzet, B., Bettler, B., Caron, M. G., Wettstein, J. G., and Hoener, M. C. (2011). TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc. Natl. Acad. Sci. U.S.A. 108, 8485-8490.
51. Shenoy, S. K., and Lefkowitz, R. J. (2011). β-Arrestin-mediated receptor trafficking and signal transduction. Trends Pharmacol. Sci. 32, 521-533.
52. Shenoy,S.K.,McDonald,P.H.,Kohout, T.A.,andLefkowitz,R.J. (2001).Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science 294,1307-1313.
53. Shukla, A. K., Violin, J. D., Whalen, E. J., Gesty-Palmer, D., Shenoy, S. K., and Lefkowitz, R. J. (2008). Distinct conformational changes in beta-arrestin report biased agonism at seven-transmembrane receptors. Proc. Natl. Acad. Sci. U.S.A. 105, 9988-9993.
54. Small, K. M., Schwarb, M. R., Glinka, C., Theiss, C. T., Brown, K. M., Seman, C. A., and Liggett, S. B. (2006). Alpha2Aand alpha2Cadrenergic receptors form homoand heterodimers: the heterodimeric state impairs agonist-promoted GRK phosphorylation and beta-arrestin recruitment. Biochemistry 45, 4760-4767.
55. Sotnikova, T. D., Caron, M. G., and Gainetdinov, R. R. (2009). Trace amine-associatedreceptorsasemergingtherapeutictargets.Mol.Pharmacol. 76,229-235.
56. Vilardaga, J. P., Bunemann, M., Krasel, C., Castro, M., and Lohse, M. J. (2003). Measurement of the millisecond activation switch of G protein-coupled receptors in living cells. Nat. Biotechnol. 21, 807-812.
57. Violin, J. D., DiPilato, L. M., Yildirim, N., Elston, T. C., Zhang, J., and Lefkowitz, R. J. (2008). β2Adrenergic receptor signaling and desensitization elucidated by quantitative modeling of real time cAMP dynamics. J. Biol. Chem. 283, 29492961.
58. Whalen, E. J., Rajagopal, S., and Lefkowitz, R. J. (2011). Therapeutic potential of beta-arrestinand G protein-biased agonists. Trends Mol. Med. 17,126-139.
59. Xu, Y., Piston, D. W., and Johnson, C. H. (1999). A bioluminescence resonanceenergytransfer(BRET)system: application to interacting circadian clock proteins. Proc. Natl. Acad. Sci. U.S.A. 96, 151-156.